Collaborate Disseminate
Next-gen anti-obesity drugs like injectable liraglutide, sold as Saxenda, deliver impressive results in the first 12 months. New research looks into what happens to those results once treatment stops.Continue ReadingCategory: Health & Wellbeing, Li… Continue reading What happens when you go off weight-loss drugs?
In yet another surprise attribute of the new class of obesity drugs, scientists have found that GLP-1 receptor agonists can also subdue brain inflammation, giving them a potential ‘superpower’ in the fight against Alzheimer’s and Parkinson’s diseases.
Tags: University of Toronto, Ozempic, GLP1, Alzheimer’s Disease, Parkinson’s Disease, Inflammatory, Brain, Dementia
Continue reading GLP-1 weight-loss drugs may pivot to treat Alzheimer’s and Parkinson’s